Recruitment and retention of participants can be challenging in clinical studies, especially in long-term clinical trials. The increase in the number and complexity of eligibility criteria for different clinical trials has further complicated the process of recruitment. To improve the uniformity of this process and facilitate the inclusion of a diverse population, the USFDA and the National Cancer Institute collaborated with a renowned nonprofit organization to release a set of guidelines.
The guidelines particularly focus on 13 important factors that need to be considered while recruiting patients for clinical trials on non-small cell lung cancer. They were as follows: Disease staging The first criterion must mention the stage and histological features of the disease. Patients with metastases and those with advanced-stage cancer who are unresponsive to curative treatment may also be…
